IndiaOne Finance - Company Dashboard

Governance Classic Home

Jeena Sikho Lifecare LtdPharmaceuticalsINE0J5801029Consolidated₹509.65+18.85 (+3.84%)Jun-26

Valuation

Market Cap₹6.34K Cr

TTM PE26.83x

Forward PE26.79x

PEG4.10

Book Value₹37.58

P/B13.58x

TTM EPS₹19.02

Fwd EPS₹19.05

TTM Revenue₹851.48 Cr

TTM PAT₹236.32 Cr

TTM EBITDA₹362.74 Cr

TTM EBIT₹309.31 Cr

Last Qtr PAT₹65.89 Cr

Last Qtr EBITDA₹92.06 Cr

Last Qtr EBIT₹76.67 Cr

Profitability

ROE50.60%

ROCE57.72%

TTM NPM27.75%

TTM EBITDA %42.60%

Curr OPM27.60%

Last OPM20.59%

Curr NPM—

Last NPM—

Curr EPS₹5.30

Last EPS₹3.63

Balance sheet

Equity₹24.86 Cr

Reserve₹442.22 Cr

Total Debt₹106.46 Cr

D/E0.23x

Interest %5.27%

Curr Interest₹3.47 Cr

Price / range

Close₹510.40

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+4.00%

1W-0.13%

1M+0.43%

3M-7.30%

6M-18.86%

1Y-37.92%

2Y—

3Y—

5Y—

Diwali-25.03%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	224.40+28.8%	215.55	221.67	189.85	174.29	801.35
Other Income	14.02	3.58	2.57	1.44	1.07	8.66
Total Income	238.42+36.0%	219.13	224.23	191.29	175.35	810.01
Interest	3.47	3.73	3.10	4.35	1.66	12.83
Expenditure	-151.08-41.5%	-157.63	-135.17	-112.53	-106.80	-512.13
PBDT	0	0	0	0	0	0
EBITDA	92.12+16.9%	77.97	100.81	92.07	78.80	349.63
Depreciation	-15.33	-16.32	-11.21	-10.40	-9.65	-47.58
EBIT	76.79+11.0%	61.65	89.60	81.67	69.15	302.05
PBT	87.34+27.4%	61.50	89.06	78.76	68.55	297.87
Tax	-21.64	-16.15	-22.33	-19.98	-17.24	-75.70
Equity	24.86	24.86	0	24.86	24.86	24.86
OPM	36.63	28.07	40.18	41.17	39.09	36.77
Net Profit	65.69+28.0%	45.35	66.73	58.79	51.31	222.18
NPM	27.55	20.70	30.10	30.73	29.26	27.43
EPS	5.28+27.8%	3.65	5.37	4.73	4.13	17.87

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	801.35
Other Income	8.66
Total Income	810.01
Expenditure	-512.13
Interest	-12.83
PBDT	0
EBITDA	349.63
Depreciation	-47.58
EBIT	302.05
PBT	297.87
Tax	-75.70
Equity	24.86
OPM (%)	36.77
Net Profit	222.18
NPM (%)	27.43
EPS (Rs)	17.87
CEPS	17.85

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	224.40+28.8%	215.55	221.68	189.85	174.29	801.36
Other Income	14.33	3.42	2.57	1.44	1.07	8.50
Total Income	238.73+36.1%	218.97	224.25	191.29	175.35	809.86
Interest	3.47	3.73	3.10	4.35	1.66	12.83
Expenditure	-151.20-41.5%	-157.74	-135.32	-112.56	-106.84	-512.47
PBDT	0	0	0	0	0	0
EBITDA	92.06+16.9%	77.92	100.72	92.04	78.76	349.41
Depreciation	-15.39	-16.38	-11.26	-10.40	-9.65	-47.69
EBIT	76.67+10.9%	61.54	89.46	81.64	69.11	301.72
PBT	87.53+27.8%	61.23	88.93	78.73	68.51	297.39
Tax	-21.64	-16.15	-22.33	-19.98	-17.24	-75.70
Equity	24.86	24.86	0	24.86	24.86	24.86
OPM	36.66	27.96	39.66	41.16	39.07	36.72
Net Profit	65.89+28.5%	45.08	66.60	58.75	51.27	221.70
NPM	27.60	20.59	29.70	30.71	29.24	27.37
EPS	5.30+28.3%	3.63	5.36	4.73	4.13	17.84

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	801.36
Other Income	8.50
Total Income	809.86
Expenditure	-512.47
Interest	-12.83
PBDT	0
EBITDA	349.41
Depreciation	-47.69
EBIT	301.72
PBT	297.39
Tax	-75.70
Equity	24.86
OPM (%)	36.72
Net Profit	221.70
NPM (%)	27.37
EPS (Rs)	17.84
CEPS	17.81

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1.1	22 Sep 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split